In the subgroup analysis, the prognostic significance of serum uPA was highest in patients with HER2-positive disease, followed by the triple-negative subtype; in patients with hormone receptor positive HER2-negative disease tumor, the impact of uPA levels on OS and PFS was not significant (Table 3). This evidence concerns the gene NR4A1 and neoplasm.